title: [Sugammadex use experience in pediatric oncology].
abstract: Sugamnmadex is a new type agent for reversal of neuromuscular blockade in any stage. There are foreign and home sugammadex use studies; however the information of sugammadex use in Pediatric patients is not enough. The article deals with study results of sugammadex use in Pediatric surgical oncology for the reversal of neuromuscular blockade by the agent rocuronium. 42 Pediatric patients in age from 2 to 17 years after elective oncology surgeries were recruited in the study. The speed and entirety of myorelaxation shifting as an evidence of sugammadex effectiveness were assessed by the accelerometer.
authors.forename: N V
authors.initials: NV
authors.lastname: Matinyan
authors.forename: A I
authors.initials: AI
authors.lastname: Saltanov
authors.forename: A A
authors.initials: AA
authors.lastname: Mareeva
mesh_terms: D061725:Accelerometry; D000293:Adolescent; D000367:Age Factors; D000732:Androstanols / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D009369:Neoplasms / Q000601:surgery; D019148:Neuromuscular Blockade / Q000379:methods*; D003473:Neuromuscular Nondepolarizing Agents / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D000077123:Rocuronium; D000077122:Sugammadex; D013997:Time Factors; D047408:gamma-Cyclodextrins / Q000627:therapeutic use*
chemical_list: D000732:Androstanols; D003473:Neuromuscular Nondepolarizing Agents; D047408:gamma-Cyclodextrins; D000077122:Sugammadex; D000077123:Rocuronium